Can Tegretol (carbamazepine) cause severe pupil dilation, also known as mydriasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Tegretol Cause Severe Pupil Dilation?

Tegretol (carbamazepine) is not directly associated with causing severe pupil dilation (mydriasis) as a primary adverse effect. The available guideline evidence does not list pupillary dilation among carbamazepine's recognized side effects, and the drug lacks the anticholinergic properties that typically cause this reaction.

Evidence from Guidelines

The American Family Physician guidelines on managing Alzheimer's disease list carbamazepine as a mood-stabilizing agent with "problematic side effects" requiring monitoring of complete blood cell counts and liver enzyme levels, but pupillary changes are not mentioned among these concerns 1.

Mechanism and Drug Class Considerations

Carbamazepine does not possess significant anticholinergic activity, which is the primary mechanism by which medications cause pupillary dilation 2. The American Academy of Ophthalmology notes that anticholinergic medications cause pupillary dilation through their effects on the iris sphincter muscle, and systemic side effects of anticholinergic agents include fever, dry mouth, rapid pulse, nausea, vomiting, flushing, and somnolence 2.

Medications That Do Cause Pupillary Dilation

For context, drugs that commonly cause mydriasis include:

  • Anticholinergic agents (tricyclic antidepressants, typical antipsychotics, antihistamines) which can cause transient mydriasis and potentially precipitate angle-closure glaucoma in susceptible patients 3, 4
  • Sympathomimetic agents (cocaine, methylphenidate, amphetamines) 5
  • Topical cycloplegic agents used in ophthalmology (cyclopentolate, tropicamide, atropine) 1, 2

Ocular Side Effects of Carbamazepine

Research evidence indicates that carbamazepine's ocular adverse effects primarily involve ocular dystonias (especially in polytherapy) and impairment in color perception and contrast discrimination 3. A comprehensive review of antiepileptic side effects mentions angle-closure glaucoma, but this is not mediated through pupillary dilation mechanisms 6.

Clinical Caveat

If a patient on carbamazepine presents with severe pupillary dilation, investigate alternative causes including:

  • Concomitant medications with anticholinergic properties
  • Accidental or intentional exposure to mydriatic agents
  • Neurological emergencies (the American Heart Association notes that ipsilateral pupillary dysfunction and mydriasis indicate deterioration in hemispheric stroke, though this is unrelated to carbamazepine) 1
  • Acute angle-closure glaucoma from other susceptibilities

The absence of pupillary dilation in carbamazepine's side effect profile across multiple authoritative guidelines strongly suggests this is not a recognized adverse effect of the medication 1, 3, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anticholinergic Medications and Pupillary Dilation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drug-induced ocular disorders.

Drug safety, 2008

Research

Ocular side effects of selected systemic drugs.

Optometry clinics : the official publication of the Prentice Society, 1992

Research

Side effects of antiepileptics--a review.

Pain practice : the official journal of World Institute of Pain, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.